Search results
Reference Standards Catalog. USP currently offers more than 3,500 Reference Standards—highly characterized specimens of drug substances, excipients, food ingredients, impurities, degradation products, dietary supplements, compendial reagents and performance calibrators. Click below to download the full list. Download as PDF. Download as Excel.
Aug 4, 2015 · You may not know about the United States Pharmacopeia (USP), but chances are you’ve been positively impacted by our activities. Here are some facts about who we are, what we do, and what it means to you. FACT: USP is the only independent, not-for-profit, nongovernmental pharmacopeia in the world.
USP–NF is a combination of two compendia, the United States Pharmacopeia (USP) and the National Formulary (NF).
Aug 7, 2014 · Few people understand the meaning or function of a pharmacopeia, but it plays an important role in safeguarding public health. The idea of documenting...
Jul 14, 2015 · Documentary standards (also known as monographs)—covering everything from developing a drug to storing it—appear in our reference text, the United States Pharmacopeia-National Formulary ( USP–NF ). A USP Reference Standard (also known as a physical standard) is a known quantity of a drug substance or ingredient, developed in alignment ...
USP Convention Over 200 years ago the first meeting of the USP Convention was held. On that day in 1820, 11 doctors gathered to establish standards for medicines to help ensure that the medicines prescribed, were the medicines taken, regardless of where a patient lived. Since then, the Convention has grown significantly and its impact has expanded across the globe, but its purpose remains much ...
The United States Pharmacopeia–National Formulary (USP–NF) is continuously revised. Revisions are presented three times a year in the USP-NF as Issues 1, 2, and 3, and as monthly Accelerated Revisions on the USP website. USP uses its Accelerated Revision processes to expedite revisions to the USP–NF. Accelerated Revisions include Revision ...
